Search Invivoscribe Technologies LLC Products
Invivoscribe, through its wholly-owned subsidiaries LabPMM, is a leading provider of clinically-validated personalized molecular diagnostics. We provide access to cutting edge testing to physicians and cancer centers world wide, enabling doctors to determine the most successful method of treatment for each patient. The company and its subsidiaries provide one stop comprehensive care for patients in over 50 countries. Invivoscribe's CE-marked IVD products are used to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative diseases. The company's CLIA- and CAP-accredited clinical reference laboratories, LabPMM LLC & LabPMM GmbH, are the only clinical laboratories outside Japan licensed to perform FLT3 biomarker testing, and the only laboratories in the world licensed to determine the mutation status of both FLT3 and NPM1.
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.